EGFr dinucleotide repeat polymorphism in non-small cell lung cancer.

被引：0
|
作者：
Dubey, S
Miller, J
Stephenson, P
Keller, SM
Johnson, DH
Schiller, JH
Kolesar, JM
机构：
[1] Univ Wisconsin, Eastern Cooperat Oncol Grp, Madison, WI USA
[2] Univ Wisconsin, Sch Pharm, Madison, WI USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Vanderbilt Univ, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9585
引用
收藏
页码：856S / 856S
页数：1
相关论文
共 50 条
  • [21] Is EGFR expression important in non-small cell lung cancer?
    Lee, SM
    THORAX, 2006, 61 (02) : 98 - 99
  • [22] EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
    Gerber, David E.
    DRUG DEVELOPMENT RESEARCH, 2008, 69 (06) : 359 - 372
  • [23] Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
    Crintea, Andreea
    Constantin, Anne-Marie
    Motofelea, Alexandru C.
    Crivii, Carmen-Bianca
    Velescu, Maria A.
    Coseriu, Razvan L.
    Ilyes, Tamas
    Craciun, Alexandra M.
    Silaghi, Ciprian N.
    JOURNAL OF FUNCTIONAL BIOMATERIALS, 2023, 14 (09)
  • [24] Miliary EGFR mutated non-small cell lung cancer
    Nguyen, Mike M.
    Moore, Melissa M.
    MEDICAL JOURNAL OF AUSTRALIA, 2021, 214 (03) : 118 - 118
  • [25] Comparison of EGFR FISH and EGFR SISH in non-small cell lung cancer
    Wulf, M.
    Behnke, S.
    Soltermann, A.
    Tischler, V
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 153 - 153
  • [26] MICROSATELLITE INSTABILITY AT SELECTED TETRA-NUCLEOTIDE REPEAT SEQUENCE IN NON-SMALL CELL LUNG CANCER.
    Arai, Hiromasa
    Okudela, Koji
    Oshio, Hisashi
    Komitsu, Noriko
    Nishii, Teppei
    Tsuboi, Masahiro
    Nozawa, Akinori
    Noishiki, Yasuharu
    Inui, Kenji
    Masuda, Munetaka
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S463 - S463
  • [27] The landscape of EGFR exon 20 insertion mutations in Chinese patients with non-small cell lung cancer.
    Xu, Shun
    Fu, Zhichao
    CANCER RESEARCH, 2022, 82 (12)
  • [28] Targeted COX-2 and EGFR TK inhibition in advanced non-small cell lung cancer.
    Reckamp, K. L.
    Czernin, J.
    Weber, W. A.
    Dubinett, S. M.
    Figlin, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 408S - 408S
  • [29] Role of AKT3 in EGFR-TKI resistance of non-small cell lung cancer.
    Huang, Shih-Hsiang
    Shih, Jin-Yuan
    Chen, Ching-Chow
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 55 - 55
  • [30] Development of cMET/cMET/EGFR Trispecific antibody as therapeutic modality for Non-small Cell Lung Cancer.
    Zaman, Mohd
    Huang, Cai
    Kankanamalage, Sachith Gallolu
    Chaudhary, Amit K.
    Dong, Jianbo
    Liu, Yue
    CANCER RESEARCH, 2021, 81 (13)
12345